Meridian Bioscience Reports Third Quarter 2019 Operating Results
CINCINNATI, Ohio, July 30, 2019 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter and first nine months ended June 30, 2019. Third Quarter 2019 Highlights (Comparison to Third Quarter Fiscal 2018): Consolidated revenue decreased 6% to $48.4 million (5% decrease in constant-currency) Diagnostics segment revenues decreased 9% […]